2002
DOI: 10.1002/ana.10213
|View full text |Cite
|
Sign up to set email alerts
|

Periaxin mutations cause a broad spectrum of demyelinating neuropathies

Abstract: Previous studies have demonstrated that apparent loss-of-function mutations in the periaxin gene cause autosomal recessive Dejerine-Sottas neuropathy or severe demyelinating Charcot-Marie-Tooth disease. In this report, we extend the associated phenotypes with the identification of two additional families with novel periaxin gene mutations (C715X and R82fsX96) and provide detailed neuropathology. Each patient had marked sensory involvement; two siblings with a homozygous C715X mutation had much worse sensory im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
80
0
3

Year Published

2003
2003
2016
2016

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 110 publications
(87 citation statements)
references
References 23 publications
(40 reference statements)
4
80
0
3
Order By: Relevance
“…Similar clinical manifestations are observed in patients carrying mutations in different genes, while variable presentations are present even in patients with an identical mutation in the same gene. Recently, there have been several reports that the periaxin (PRX) mutations were detected in the patients showing early onset of symptoms, but with slow or no progression (Boerkoel et al 2001;Guilbot et al 2001;Takashima et al 2002;Kijima et al 2004). We found heterozygous R1070X and L132fsX153 compound mutations of PRX in another patient showing early onset but no progressive clinical symptoms.…”
Section: Introductionmentioning
confidence: 60%
See 1 more Smart Citation
“…Similar clinical manifestations are observed in patients carrying mutations in different genes, while variable presentations are present even in patients with an identical mutation in the same gene. Recently, there have been several reports that the periaxin (PRX) mutations were detected in the patients showing early onset of symptoms, but with slow or no progression (Boerkoel et al 2001;Guilbot et al 2001;Takashima et al 2002;Kijima et al 2004). We found heterozygous R1070X and L132fsX153 compound mutations of PRX in another patient showing early onset but no progressive clinical symptoms.…”
Section: Introductionmentioning
confidence: 60%
“…L-periaxin has four characteristic domains: PDZ, NLS, repeat and acidic domains (Gillespie et al 1994;Sherman and Brophy 2000;Sherman et al 2001). To date, nine pedigrees, carrying ten nonsense or frameshift mutations of PRX, have been reported (Boerkoel et al 2001;Guilbot et al 2001;Takashima et al 2002;Kijima et al 2004). It is interesting to note that all nine mutations are predicted to produce mutant proteins that lack an acidic domain.…”
Section: Discussionmentioning
confidence: 99%
“…Among the 479 DEGs downregulated at 10 dpi, 120 DEGs mapped to "nervous system development" and "neurogenesis" (Table 2). In addition to GFAP, which was the most downregulated gene (FC of 75), other notable DEGs mapping to these GO terms include periaxin (PRX, FC of 20, important for the ensheathment of neurons and axons [89]), CPLX1 (FC of 16, regulating synaptic vesicle exocytosis), and proprotein convertase subtilisin/kexin type 1 inhibitor (ProSAAS, FC of 17, neural tissue inhibitor of prohormone convertase 1, which is involved in insulin synthesis [90]). …”
Section: Fig 7 Immunohistochemistry Gene Validation Ihc Staining Andmentioning
confidence: 99%
“…Resulta de mutações no gene da periaxina (PRX), localizado no cromossomo 19q13.1-13.2 55,56 . Seus 2 subcomponentes (periaxina L e S) são essenciais para a formação e manutenção da mielina periférica 57 .…”
Section: Cmt4funclassified